Aptamer Group PLC Sustainability Reports
The company develops custom affinity binders through its proprietary Optimer platform to enable new approaches in therapeutics, diagnostics, and research applications. It provides biotechnology-driven contract research and development solutions to global pharmaceutical and life science innovators.
Sector: Professional & technical services
Country: United Kingdom
Exchange: London Stock Exchange (AIM)
LEI: 213800Y4XGH3WJNBE686
FIGI: BBG00LB9FBW5
4 reports from 2022 to 2025
